MinuteClinic lists semaglutide among FDA-approved weight-loss medications its providers can prescribe if eligible.
Tirzepatide
MinuteClinic lists tirzepatide among FDA-approved weight-loss medications its providers can prescribe if eligible.
MinuteClinic states that compounded GLP-1 medications are not prescribed there and that prescribing may not be available in all states.
Locations in the source record
A current location was not established by the evidence reviewed.
Services named by sources
Retail prescription pharmacy
MinuteClinic weight-loss consultations
FDA-approved GLP-1 prescribing when clinically appropriate
Prescription fulfillment
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Not conclusively established
The captured CVS source describes FDA-approved weight-loss prescribing and explicitly says MinuteClinic does not prescribe compounded GLP-1 drugs. It does not establish a chain-wide 503A classification.
Section 503B
Not conclusively established
No exact CVS entity/facility was verified by FDA as a 503B outsourcing facility.
What remains unverified
Founded year
Complete state license footprint
Chain-wide 503A status
Any CVS 503B facility
Exhaustive federal and state regulatory-action history
Telehealth providers
No telehealth-provider relationship is verified in the sources we checked.
Clinic Scout links a provider only when an explicit source names the relationship.
The cited DOJ civil complaint was reviewed. This was not an exhaustive search of CVS's extensive federal and state regulatory history, and no compounding-specific FDA action was attributed to CVS in this wave.
U.S. Department of Justice · 2024-12-18
Civil Complaint / Lawsuit
DOJ announced a nationwide civil complaint alleging that CVS filled unlawful controlled-substance prescriptions and sought federal reimbursement for unlawful prescriptions. The cited release expressly says the claims are allegations and that liability had not been determined.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 1 regulatory/action record(s), and 5 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
Know when GLP-1 prices move.
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.